William M. Brown - 26 Apr 2022 Form 4 Insider Report for Celanese Corp (CE)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
27 Apr 2022, 16:05:18 UTC
Prior SEC filing
10 Mar 2022
Next SEC filing
05 May 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Adam R. Santosuosso, Attorney-in-Fact for William M. Brown
Filing notes and source

Key filing fact

William M. Brown filed Form 4 for Celanese Corp (CE) on 27 Apr 2022.

Key facts

  • This page summarizes William M. Brown's Form 4 filing for Celanese Corp (CE).
  • 3 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 27 Apr 2022, 16:05.

Change

  • Previous filing in this sequence was filed on 10 Mar 2022.
  • Current net transaction value: +$9,062.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CE transaction

Common Stock

Disposed to Issuer

Transaction value
Shares
-975
Change %
-90%
Price
Shares after
103
Date
27 Apr 2022
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CE transaction Derivative

Phantom Stock

Award

Transaction value
$9,062
Shares
+65
Change %
+0.67%
Price
$139.24
Shares after
9,794
Date
26 Apr 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
65
Exercise price
Footnotes
F2, F3, F4
CE transaction Derivative

Phantom Stock

Award

Transaction value
$0
Shares
+975
Change %
+10%
Price
$0.000000
Shares after
10,769
Date
27 Apr 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
975
Exercise price
Footnotes
F5, F6
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

Upon vesting of 975 Restricted Stock Units granted to the reporting person on April 27, 2021, the reporting person deferred the receipt of 975 shares of Common Stock and received instead 975 shares of phantom stock pursuant to the Company's 2008 Deferred Compensation Plan (the "Plan"). As a result, the reporting person is reporting the disposition of 975 shares of Common Stock in exchange for an equal number of shares of phantom stock.

Footnote F2

Each share of phantom stock represents the right to receive the cash value of one share of Common Stock.

Footnote F3

The reported phantom stock represents the reporting person's quarterly cash retainer for service as a director which has been deferred under the Plan.

Footnote F4

As provided in the Plan, the reporting person may transfer a portion of the phantom stock account into an alternative investment account at any time, and on the earlier of the date previously elected by the reporting person to receive a payment or the termination of the reporting person's service as a director of the Company, the shares of phantom stock become payable in either cash or shares of Common Stock.

Footnote F5

Each share of phantom stock represents the right to receive one share of Common Stock.

Footnote F6

As provided in the Plan, the reported phantom stock becomes payable in shares of Common Stock upon termination of the reporting person's service as a director of the Company subject to certain restrictions and limitations.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .